Skip to content
Home/Companies/Biotech/Zihpp

Zihpp

Biotech·UK·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Zihpp?

Zihpp was owned by IP Group through IP Group (Evergreen) (2001 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-16

IP Group
Investor
IP Group
IP Group (Evergreen) · 2001 · Evergreen

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from IP Group (Evergreen)

Other portfolio companies in the same fund.

Mantle8
Mantle8
Active
ClimateTechFrance· 2025
AirForestry
Active
ClimateTechSweden· 2024
Lumai
Lumai
Active
AI/MLUK· 2022
Atisama Therapeutics
Active
BiotechAustralia· 2021
Centessa Pharmaceuticals
Centessa Pharmaceuticals
Active
BiotechUS· 2021
Hysata
Active
ClimateTechAustralia· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Zihpp

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Zihpp.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue